LUCA, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.230
EU - Europa 388
AS - Asia 190
AF - Africa 31
SA - Sud America 12
OC - Oceania 5
Totale 1.856
Nazione #
US - Stati Uniti d'America 1.211
IT - Italia 139
SE - Svezia 109
IN - India 81
FI - Finlandia 53
CN - Cina 46
SG - Singapore 41
TG - Togo 31
CA - Canada 15
DE - Germania 14
BG - Bulgaria 13
UA - Ucraina 12
GB - Regno Unito 11
NL - Olanda 10
AR - Argentina 9
BE - Belgio 7
IR - Iran 7
IE - Irlanda 6
TW - Taiwan 6
FR - Francia 5
CH - Svizzera 4
MX - Messico 4
NZ - Nuova Zelanda 4
BR - Brasile 3
KR - Corea 2
RO - Romania 2
TR - Turchia 2
AU - Australia 1
BT - Bhutan 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
MY - Malesia 1
Totale 1.856
Città #
Fairfield 194
Chandler 127
Dearborn 91
Ashburn 86
Seattle 73
Woodbridge 65
Cambridge 59
Houston 59
Wilmington 52
Rome 49
Ann Arbor 41
Princeton 36
Plano 34
Lomé 31
Fremont 30
Helsinki 22
San Paolo di Civitate 20
Millbury 19
Singapore 19
Beijing 16
Lawrence 16
Boston 15
San Diego 14
Napoli 13
Sofia 13
Toronto 11
Houten 8
Guangzhou 7
Semnan 7
Andover 6
Beitou 6
Cagliari 6
Dublin 6
Milan 6
Norwalk 6
Velletri 6
Brussels 5
Federal 5
San Mateo 5
Bern 4
Buenos Aires 4
Guwahati 4
Hefei 4
Ottawa 4
Caserta 3
Chongqing 3
Frascati 3
Indiana 3
Jacksonville 3
London 3
Lynchburg 3
Mannheim 3
Naples 3
Bari 2
Boardman 2
Bühl 2
Des Moines 2
Edinburgh 2
Falls Church 2
Grafing 2
Istanbul 2
Kunming 2
Marano di Napoli 2
Mexico City 2
Nanchang 2
Nanjing 2
New York 2
Redmond 2
Redwood City 2
Rovellasca 2
Saint-Fons 2
Shanghai 2
Shenyang 2
São Paulo 2
Waanrode 2
Anaheim 1
Aversa 1
Budapest 1
Buffalo 1
Central 1
Cernusco sul Naviglio 1
Chandannagar 1
Cinisello Balsamo 1
Coventry 1
Erlangen 1
Frankfurt am Main 1
Islington 1
Jinan 1
Kota 1
Langfang 1
Lanzhou 1
Logroño 1
Melbourne 1
New Bedfont 1
Phoenix 1
Prescot 1
Provo 1
Rende 1
Santiago 1
Southend 1
Totale 1.400
Nome #
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 93
Cell-density dependence of host-defense peptide activity and selectivity in the presence of host cells 88
Naturally occurring peptides from Rana temporaria: antimicrobial properties and more 87
Membrane perturbing activities and structural properties of the frog-skin derived peptide esculentin-1a(1-21)NH2 and its diastereomer esc(1-21)-1c: correlation with their antipseudomonal and cytotoxic activity 85
Effects of aib residues insertion on the structural–functional properties of the frog skin-derived peptide esculentin-1a(1–21)NH2 84
Synergistic fungicidal activity of the lipopeptide bacillomycin D with amphotericin B against pathogenic Candida species 84
Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: in vitro and in vivo studies in a Caenorhabditis elegans infection model 75
Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: the case of killerFLIP 75
The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: Identification of a potent anti-Candida peptide. 71
Fighting microbial infections: A lesson from amphibian skin-derived esculentin-1 peptides 71
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa 69
Esculentin-1 aderived antipseudomonal peptides. limited induction of resistance and synergy with aztreonam 68
Rational modification of a dendrimeric peptide with antimicrobial activity: Consequences on membrane-binding and biological properties 67
Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus. 65
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 58
Anti-Pseudomonal activity of the amphibian antimicrobial peptide Esculentin(1-21) and plausible mode of action 55
Bacillomycin d and its combination with amphotericin b: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency 55
Membrane-active derivatives of the frog skin peptide Esculentin-1 against relevant human pathogens 51
How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23 50
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 49
Membrane interaction and antibacterial properties of two mildly cationic peptide diastereomers, bombinins H2 and H4, isolated from Bombina skin 46
Membrane interaction and antimicrobial features of two peptide diastereomers from Bombina skin. 45
Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b. 44
Esc1-21 a Novel Antimicrobial Peptide for Microbial Keratitis 44
A frog skin-derived antimicrobial peptide against Pseudomonas aeruginosa-induced infections 44
Derivatives of esculentin-1a: promising frog-skin peptides for the development of new antipseudomonal drugs with expanding properties 42
Anti-pseudomonas activity of frog skin antimicrobial peptide in Caenorhabditis elegans infection model. 41
Frog skin antimicrobial peptides promote survival of Caenorhabditis elegans infected by a multi-drug resistant strain of Pseudomonas aeruginosa 38
Esculentin-1a(1-21)NH2: a promising peptide for prevention and eradicatin of Pseudomonas aeruginosa biofilm formation on soft contact-lenses 35
Esc(1-21) a novel antimicrobial peptide for microbial keratitis? 33
The effect of d-amino acids in the target cell selectivity of the frog skin peptide temporin L. 31
Bombinins. 28
Novel alpha-MSH peptide analogues with broad spectrum antimicrobial activity. 24
Synthesis and antimicrobiological evaluation of Temporin A analogues substituted with L-alanine. 23
Totale 1.918
Categoria #
all - tutte 4.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020464 59 10 4 17 45 101 73 53 50 24 12 16
2020/2021137 8 24 2 21 5 30 0 18 19 7 2 1
2021/2022324 0 27 35 5 46 13 10 34 17 27 41 69
2022/2023450 71 117 44 25 37 44 2 41 44 7 17 1
2023/2024213 12 33 4 7 8 22 2 61 2 16 34 12
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.918